Literature DB >> 30275788

Advances in Neuro-Oncology Imaging Techniques.

Brannan E O'Neill1, Christian B Hochhalter1, Christopher Carr1, Michael J Strong1, Marcus L Ware2.   

Abstract

BACKGROUND: Central nervous system (CNS) tumors are a rare but devastating malignancy, often robbing patients of the basic quality of life. Despite advances in our understanding of the CNS tumor disease processes, the prognosis for patients with CNS tumors remains poor. Better characterization and diagnostic and monitoring approaches are necessary to assist in diagnosis and treatment of CNS tumors. One important tool in the neuro-oncology armamentarium is the use of advanced imaging techniques.
METHODS: We searched PubMed using the keywords neuro-oncology imaging, pseudoprogression, molecular imaging, and biomarkers. We limited our search to full-text English articles and identified other relevant articles from the reference lists of previously identified articles.
RESULTS: Advances in imaging techniques have allowed investigators to explore various imaging modalities, from tumor characterization to differentiating pseudoprogression from tumor progression. Better imaging can result in better diagnostic approaches, greater and safer resection techniques, and improved monitoring of tumor progression.
CONCLUSION: This review highlights advances in neuro-oncology imaging techniques and their clinical utility in the treatment and management of primary brain tumors.

Entities:  

Keywords:  Biomarkers; glioma; magnetic resonance imaging; molecular imaging; multimodal imaging; surgical oncology

Year:  2018        PMID: 30275788      PMCID: PMC6162138          DOI: 10.31486/toj.17.0062

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  34 in total

Review 1.  Neuroimaging in neuro-oncology.

Authors:  Soonmee Cha
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

2.  Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features.

Authors:  Michael D Jenkinson; Daniel G du Plessis; Trevor S Smith; Kathy A Joyce; Peter C Warnke; Carol Walker
Journal:  Brain       Date:  2006-05-02       Impact factor: 13.501

Review 3.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

4.  Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Authors:  Haruka Itakura; Achal S Achrol; Lex A Mitchell; Joshua J Loya; Tiffany Liu; Erick M Westbroek; Abdullah H Feroze; Scott Rodriguez; Sebastian Echegaray; Tej D Azad; Kristen W Yeom; Sandy Napel; Daniel L Rubin; Steven D Chang; Griffith R Harsh; Olivier Gevaert
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

5.  Identification of noninvasive imaging surrogates for brain tumor gene-expression modules.

Authors:  Maximilian Diehn; Christine Nardini; David S Wang; Susan McGovern; Mahesh Jayaraman; Yu Liang; Kenneth Aldape; Soonmee Cha; Michael D Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-24       Impact factor: 11.205

Review 6.  Circulating biomarkers for gliomas.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

Review 7.  GRE T2∗-weighted MRI: principles and clinical applications.

Authors:  Meng Yue Tang; Tian Wu Chen; Xiao Ming Zhang; Xiao Hua Huang
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

8.  The application of magnetic nanoparticles for the treatment of brain tumors.

Authors:  Keon Mahmoudi; Costas G Hadjipanayis
Journal:  Front Chem       Date:  2014-12-03       Impact factor: 5.221

9.  Magnetic Resonance Spectroscopy and Single-Photon Emission Computed Tomography in the Evaluation of Cerebral Tumors: A Case Report.

Authors:  Ioannis Siasios; Varvara Valotassiou; Eftychia Kapsalaki; Ioannis Tsougos; Panagiotis Georgoulias; Aggeliki Fotiadou; Maria Ioannou; Georgios Koukoulis; Vassilios Dimopoulos; Kostas Fountas
Journal:  J Clin Med Res       Date:  2016-11-24

10.  The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis.

Authors:  Bing Wan; Siqi Wang; Mengqi Tu; Bo Wu; Ping Han; Haibo Xu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

View more
  3 in total

1.  [Multimodal image fusion technology for diagnosis and treatment of the skull base-infratemporal tumors].

Authors:  R Yang; Q X Li; C Mao; X Peng; Y Wang; Y X Guo; C B Guo
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-02-18

2.  Combined 18F-FET PET and diffusion kurtosis MRI in posttreatment glioblastoma: differentiation of true progression from treatment-related changes.

Authors:  Francesco D'Amore; Farida Grinberg; Jörg Mauler; Norbert Galldiks; Ganna Blazhenets; Ezequiel Farrher; Christian Filss; Gabriele Stoffels; Felix M Mottaghy; Philipp Lohmann; Nadim Jon Shah; Karl-Josef Langen
Journal:  Neurooncol Adv       Date:  2021-03-10

Review 3.  Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas.

Authors:  Sanjeev Chawla; Vanessa Shehu; Pradeep K Gupta; Kavindra Nath; Harish Poptani
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.